Liberty Capital Management, Inc. / ABT
Liberty Capital Management, Inc.’s Abbott Laboratories Position
Does Liberty Capital Management, Inc. own Abbott Laboratories (ABT)? Yes — 48.8K shares worth $6M (+1.14% of its 13F portfolio) as of Q4 2025, up from 48.0K shares the prior filed quarter.
Position Value
$6M
Q4 2025
Shares
48.8K
% of Portfolio
+1.14%
Quarters Held
28
currently held
Position History ABT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q4 2025 | 48.8K | $6M | +1.14% |
| Q3 2025 | 48.0K | $6M | +1.21% |
| Q2 2025 | 46.3K | $6M | +1.27% |
| Q1 2025 | 43.9K | $6M | +1.30% |
| Q4 2024 | 43.9K | $5M | +1.10% |
| Q3 2024 | 43.7K | $5M | +1.10% |
| Q2 2024 | 43.6K | $5M | +1.07% |
| Q1 2024 | 40.7K | $5M | +1.14% |
| Q4 2023 | 41.0K | $5M | +1.18% |
| Q3 2023 | 41.4K | $4M | +1.18% |
| Q2 2023 | 37.1K | $4M | +1.21% |
| Q1 2023 | 36.6K | $4M | +1.22% |
| Q4 2022 | 36.8K | $4M | +1.40% |
| Q3 2022 | 36.5K | $4M | +1.32% |
| Q2 2022 | 36.9K | $4M | +1.43% |
| Q1 2022 | 36.8K | $4M | +1.27% |
| Q4 2021 | 36.6K | $5M | +1.39% |
| Q3 2021 | 38.2K | $5M | +1.33% |
| Q2 2021 | 38.2K | $4M | +1.35% |
| Q1 2021 | 37.8K | $5M | +1.56% |
| Q4 2020 | 37.6K | $4M | +1.49% |
| Q2 2020 | 36.8K | $3M | +1.46% |
| Q1 2020 | 36.2K | $3M | +1.49% |
| Q4 2019 | 35.9K | $3M | +1.28% |
| Q3 2019 | 35.9K | $3M | +1.33% |
| Q2 2019 | 36.7K | $3M | +1.39% |
| Q1 2019 | 36.5K | $3M | +1.47% |
| Q4 2018 | 36.1K | $3M | +1.61% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Liberty Capital Management, Inc.’s full portfolio or all institutional holders of ABT.